<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34603189</PMID><DateRevised><Year>2021</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome - A Report on the Clinical Presentations of the First 100 Patients.</ArticleTitle><Pagination><StartPage>738405</StartPage><MedlinePgn>738405</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">738405</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2021.738405</ELocationID><Abstract><AbstractText><b>Background and Objectives:</b> Neurological and psychiatric symptoms are frequent in patients with post-COVID-19 syndrome (PCS). Here, we report on the clinical presentation of the first 100 patients who presented to our PCS Neurology outpatient clinic &#x2265;12 weeks after the acute infection with SARS-CoV-2. To date, PCS is only defined by temporal connection to SARS-CoV-2 infection. Identification of clinical phenotypes and subgroups of PCS is urgently needed. <b>Design:</b> We assessed clinical data of our first 100 ambulatory patients regarding clinical presentations; self-questionnaires focusing on daytime sleepiness, mood, and fatigue; and a screening assessment for detecting cognitive impairment. <b>Results:</b> A total of 89% of the patients presenting to the Neurology outpatient clinic had an initially mild course of COVID-19 and had not been hospitalized. The majority of the patients were female (67 vs. 33% male). The most frequent symptom reported was cognitive impairment (72%). There were 30% of patients who reported cognitive deficits and scored below 26 points on the Montreal Cognitive Assessment Scale. Fatigue (67%), headache (36%), and persisting hyposmia (36%) were also frequently reported; 5.5% of all patients showed signs of severe depression. <b>Discussion:</b> To our knowledge, this is the first report of patient data of a PCS Neurology outpatient clinic. Neurological sequelae also exist for more than 3 months after mainly mild SARS-CoV-2 acute infections. The reported symptoms are in accordance with recently published data of hospitalized patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Boesl, Audebert, Endres, Pr&#xfc;ss and Franke.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boesl</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Audebert</LastName><ForeName>Heinrich</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Stroke Research Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Endres</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Stroke Research Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Excellence Cluster NeuroCure, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pr&#xfc;ss</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, corporate member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword><Keyword MajorTopicYN="N">neurology</Keyword><Keyword MajorTopicYN="N">outpatient</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>4</Day><Hour>5</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34603189</ArticleId><ArticleId IdType="pmc">PMC8481602</ArticleId><ArticleId IdType="doi">10.3389/fneur.2021.738405</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Overview . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19 | Guidance | NICE. (2021). Available online at: https://www.nice.org.uk/guidance/ng188</Citation></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. (2021) 325:1525&#x2013;34. 10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. (2021) 174:576&#x2013;8. 10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. . Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. (2021) 325:2015&#x2013;6. 10.1001/jama.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. (2021) 8:416&#x2013;27. 10.1016/S2215-0366(21)00084-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239&#x2013;42. 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. . More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. (2021) 11:16144. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Warnke C, Gorsler A, Pr&#xfc;&#xdf; H. Neurologische manifestationen bei patienten mit Post-COVID-19-Syndrom. DGNeurologie. (2021) 4:276&#x2013;80. 10.1007/s42451-021-00345-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42451-021-00345-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Kleineberg NN, G&#xf6;reci Y, Onur OA, Franke C, Warnke C. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis. Curr Opin Neurol. (2021) 34:423&#x2013;31 10.1097/WCO.0000000000000930</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000930</ArticleId><ArticleId IdType="pubmed">33709973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreye J, Reincke SM, Kornau H-C, S&#xe1;nchez-Sendin E, Corman VM, Liu H, et al. . A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model. Cell. (2020) 183:1058&#x2013;69.e19. 10.1016/j.cell.2020.09.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.049</ArticleId><ArticleId IdType="pmc">PMC7510528</ArticleId><ArticleId IdType="pubmed">33058755</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, et al. . High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Beha Immun. (2021) 93:415&#x2013;9. 10.1016/j.bbi.2020.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. (2021) 6:100122. 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo ST, Steyn FJ, McCombe PA. Gender differences in autoimmune disease. Front Neuroendocrinol. (2014) 35:347&#x2013;69. 10.1016/j.yfrne.2014.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2014.04.004</ArticleId><ArticleId IdType="pubmed">24793874</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch MA, Maske UE, Ryl L, Schlack R, Hapke U. Pr&#xe4;valenz von depressiver symptomatik und diagnostizierter depression bei erwachsenen in deutschland: ergebnisse der studie zur gesundheit erwachsener in deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. (2013) 56:733&#x2013;9. 10.1007/s00103-013-1688-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-013-1688-3</ArticleId><ArticleId IdType="pubmed">23703492</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep. (2008) 31:1601&#x2013;7. 10.1093/sleep/31.11.1601</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1601</ArticleId><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Wang R, Ma X, Zhao Y, Yan X, He J. Excessive daytime sleepiness assessed by the Epworth Sleepiness Scale and its association with health related quality of life: a population-based study in China. BMC Public Health. (2012) 12:849. 10.1186/1471-2458-12-849</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-849</ArticleId><ArticleId IdType="pmc">PMC3524046</ArticleId><ArticleId IdType="pubmed">23039935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayley AC, Williams LJ, Kennedy GA, Berk M, Brennan SL, Pasco JA. Prevalence of excessive daytime sleepiness in a sample of the Australian adult population. Sleep Med. (2014) 15:348&#x2013;54. 10.1016/j.sleep.2013.11.783</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2013.11.783</ArticleId><ArticleId IdType="pubmed">24513435</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorarinsdottir EH, Bjornsdottir E, Benediktsdottir B, Janson C, Gislason T, Aspelund T, et al. . Definition of excessive daytime sleepiness in the general population: feeling sleepy relates better to sleep-related symptoms and quality of life than the epworth sleepiness scale score. Results from an epidemiological study. J Sleep Res. (2019) 28:e12852. 10.1111/jsr.12852</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.12852</ArticleId><ArticleId IdType="pubmed">30968492</ArticleId></ArticleIdList></Reference><Reference><Citation>Takegami M, Sokejima S, Yamazaki S, Nakayama T, Fukuhara S. An estimation of the prevalence of excessive daytime sleepiness based on age and sex distribution of epworth sleepiness scale scores: a population based survey. Nihon Koshu Eisei Zasshi. (2005) 52:137&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">15791900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, et al. . Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany - a first analysis of a prospective observational study. medRxiv [Preprint]. (2021). 10.1101/2021.02.06.21249256</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>